Major Methylergonovine Maleate Tablets Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The Harvard Drug Group LLC is recalling 790 cartons of Major brand Methylergonovine Maleate Tablets, USP 0.2 mg due to subpotent drug.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened The Harvard Drug Group LLC initiated a voluntary recall of Methylergonovine Maleate Tablets because the product is subpotent.
Which Products Are Affected MAJOR Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), NDC 0904-7282-10. Lots: N02327 (expires 09/2026), N02740 (expires 12/2026), N03069 (expires 08/2027). 790 cartons distributed nationwide.
What You Should Do Consumers should consult their healthcare provider regarding use of the affected product.
Why This Matters A subpotent drug may not deliver the intended therapeutic effect for patients.
Source FDA recall number D-0609-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (645 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.